Genomic alterations are changes that occur within the DNA of cancer cells. Some of these changes accelerate the growth of cancer. Some respond well to specific therapies. With a clear picture of the genomic alterations in your tumor, your doctor may be able to recommend a targeted therapy. In general, targeted therapies have fewer side effects than broad-based chemotherapy. They can also be more selective in stopping the spread of a cancer when other treatments have failed.
Access new treatment options with a
breakthrough blood test
Is Guardant360 right for you?
I want to avoid the risks, potential delays, and costs of a surgical biopsy
Our test gives patients with advanced cancer comprehensive genomic information about their tumor with a simple blood draw
My cancer is progressing, and I need treatment options now
Guardant360 can help match patients with advanced cancer to new treatment options
I need to re-sequence my tumor for up-to-date results
With Guardant360, all you need is a blood sample
I want real-time monitoring of treatment response
Tumors evolve, and a simple blood draw captures the most up-to-date picture of your cancer
“I said I will be happy to give up two vials of blood if we might be able to find something.”
“I want to get through treatment again and know it's the right treatment for me”
“My medical oncologist is very much aware of the Guardant test and said 'I think this would be a really good idea.”
“I'm still here. I'm still doing great.”
Guardant360 helps patients
How Guardant360 works
It starts with a simple blood draw
All you need is an order from your doctor and two tubes of blood.
No tissue biopsy needed.
We read your cancer’s DNA
Our proprietary digital sequencing process gives us a complete picture of your cancer's genomics.
You and your doctor evaluate treatment options
Within 14 days, we'll deliver the genomic profile of your cancer, allowing you and your doctor to choose the treatment option right for your unique case.
Guardant Access manages billing
and provides financial support for Guardant360.
Know your cancer. Help fight all cancer.
Some genomic alterations are known to respond better to specific therapies. Guardant360 looks for all these clinically relevant alterations, giving your doctor the opportunity to tailor treatment to your individual cancer.
We provide results within 2 weeks of receiving your blood sample.
Yes. Guardant360 is only indicated for advanced solid tumors. It does not test for hematological cancers like leukemia, nor early stage disease.
Today Guardant360 does not predict chemotherapy response, but it does provide information on the genomic alterations known to respond to specific targeted therapies. As cancer research progresses, new response profiles may be identified.